Here, JMJD2C removes H3K9me3 marks and enhances the binding of HIF-1α leading to enhanced expression of key genes required for breast cancer progression (PDK1) and metastasis to the lung (LOXL2 and L1CAM). The gene discussed is HIF1A; the disease is breast carcinoma.